ADMS
COM:ADAMASPHARMA
Supernus Pharmaceuticals
- Stock
Last Close
8.22
01/01 00:00
Volume Today
3.15M
Avg: -
Preview
Full access to financials is available to subscribers only. Please support our work and get full access to all features. You can cancel anytime. If you'd like a demo, free trial or have any questions, please checkout the help page
Dec '13 | Dec '14 | Dec '15 | Dec '16 | Dec '17 | Dec '18 | Dec '19 | Dec '20 | ||
|---|---|---|---|---|---|---|---|---|---|
net income | 50.92M - | 10.22M 79.92% | -51.80M 606.72% | -60.06M 15.94% | -89.49M 49.01% | -131.00M 46.38% | -105.19M 19.70% | -57.40M 45.43% | |
depreciation and amortization | 66K - | 155K 134.85% | 435K 180.65% | 808K 85.75% | 1.19M 47.77% | 1.46M 22.28% | 1.21M 16.85% | 851K 29.90% | |
deferred income tax | |||||||||
stock based compensation | 640K - | 7.20M 1,025.47% | 9.96M 38.22% | 10.57M 6.18% | 13.37M 26.45% | 15.79M 18.10% | 12.85M 18.59% | 6.43M 49.96% | |
change in working capital | 56.08M - | 29.19M 47.94% | -9.60M 132.89% | 5.86M 161.07% | 55.32M 843.45% | 41.53M 24.93% | -80.72M 294.38% | -46.50M 42.39% | |
accounts receivables | 761K - | -395K 151.91% | -760K 92.41% | 490K 164.47% | 427K 12.86% | -5.14M 1,304.68% | -259K 94.97% | -2.27M 777.22% | |
inventory | -25.32M - | -82.92M 227.49% | -109.43M 31.98% | -102.37M 6.45% | -1.65M 98.39% | -3.27M 98.85% | -970K 70.36% | -2.21M 127.32% | |
accounts payables | -1.16M - | 1.52M 231.46% | -788K 151.81% | 502K 163.71% | 333K 33.67% | 2.76M 728.53% | 398K 85.57% | -4.98M 1,351.01% | |
other working capital | 81.79M - | 110.98M 35.69% | 101.38M 8.65% | 107.24M 5.78% | 56.21M 47.59% | 47.19M 16.05% | -79.89M 269.31% | -37.05M 53.63% | |
other non cash items | -80.90M - | -20.58M 74.56% | 3.80M 118.48% | -5.25M 238.13% | -47.22M 798.95% | -32.00M 32.24% | 91.07M 384.59% | 45.92M 49.58% | |
net cash provided by operating activities | 26.80M - | 26.19M 2.26% | -47.21M 280.23% | -48.07M 1.82% | -66.83M 39.03% | -104.22M 55.96% | -80.78M 22.49% | -50.71M 37.23% | |
investments in property plant and equipment | -167K - | -1.28M 669.46% | -1.40M 8.87% | -1.62M 16.08% | -1.26M 22.54% | -1.06M 15.42% | -18K 98.31% | ||
acquisitions net | |||||||||
purchases of investments | -96.09M - | -59.83M 37.74% | -103.53M 73.04% | -62.51M 39.62% | -200.35M 220.52% | -93.87M 53.15% | -68.94M 26.56% | ||
sales maturities of investments | 69.28M - | 78.44M 13.22% | 89.33M 13.88% | 132.08M 47.85% | 182.75M 38.36% | 123.88M 32.22% | |||
other investing activites | |||||||||
net cash used for investing activites | -167K - | -97.38M 58,211.38% | 8.06M 108.27% | -26.71M 431.46% | 25.57M 195.72% | -69.34M 371.22% | 88.86M 228.16% | 54.94M 38.17% | |
debt repayment | -4M - | -2.65M - | |||||||
common stock issued | 21K - | 42.63M 202,909.52% | 9.66M 77.35% | 61.82M 540.18% | 134.27M - | 1.04M - | |||
common stock repurchased | -370K - | ||||||||
dividends paid | |||||||||
other financing activites | 4.76M - | 1.15M 75.77% | 3.59M 211.01% | 108.84M 2,935.22% | 4.58M 95.79% | 1.08M 76.32% | 3.26M 200.74% | ||
net cash used provided by financing activities | -3.98M - | 47.02M 1,281.70% | 10.81M 77.01% | 65.41M 505.07% | 108.84M 66.41% | 138.85M 27.57% | 1.08M 99.22% | 1.65M 52.44% | |
effect of forex changes on cash | |||||||||
net change in cash | 22.66M - | -24.17M 206.67% | -28.34M 17.28% | -9.37M 66.94% | 67.58M 821.33% | -34.71M 151.36% | 9.17M 126.42% | 5.89M 35.81% | |
cash at beginning of period | 62.96M - | 85.61M 35.98% | 61.45M 28.23% | 33.10M 46.13% | 23.73M 28.30% | 91.32M 284.73% | 56.60M 38.01% | 65.77M 16.20% | |
cash at end of period | 85.61M - | 61.45M 28.23% | 33.10M 46.13% | 23.73M 28.30% | 91.32M 284.73% | 56.60M 38.01% | 65.77M 16.20% | 71.66M 8.95% | |
operating cash flow | 26.80M - | 26.19M 2.26% | -47.21M 280.23% | -48.07M 1.82% | -66.83M 39.03% | -104.22M 55.96% | -80.78M 22.49% | -50.71M 37.23% | |
capital expenditure | -167K - | -1.28M 669.46% | -1.40M 8.87% | -1.62M 16.08% | -1.26M 22.54% | -1.06M 15.42% | -18K 98.31% | ||
free cash flow | 26.63M - | 24.91M 6.48% | -48.61M 295.15% | -49.69M 2.23% | -68.08M 37.01% | -105.29M 54.64% | -80.80M 23.26% | -50.71M 37.24% |
All numbers in (except ratios and percentages)